The credibility problem, and how a website solves it
A life science company is judged on its science by people qualified to judge it. That makes the website unusual among B2B sites: it cannot bluff. Investors read the pipeline against their own diligence; potential collaborators read the platform section like a reviewer; candidates read the publications list before the careers page. The site either presents genuine substance in a form each audience can use, or it quietly costs the company meetings it never knows it lost.
Our builds are organised around that reality. The platform gets explained at two depths, a plain-language account for the generalist and the technical detail an expert expects, on the same indexable pages rather than in a PDF. The pipeline is structured data rendered live, so it is never a quarter out of date. Publications, posters and people are content types with proper pages, which is both good scholarship and, not coincidentally, exactly what makes a life science site findable.
Who this is for
Clinical and preclinical biotechs presenting a platform and pipeline. Laboratories, diagnostics companies and CROs selling services to diligence-minded buyers. Research institutes and groups that need their output discoverable. And the suppliers around them, instruments, reagents, informatics, whose buyers are the same experts with the same standards.
The search strategy for this audience, including the biotech and pharma SEO work, lives with our healthcare and wellness SEO practice, and the two engagements are frequently bought together: the build makes the substance indexable, the SEO makes it found.